HCA Health Inc vs Liquidia Corporation Common Stock — how do they compare? HCA Health Inc trades at $474.89 (market cap $101.85B), while Liquidia Corporation Common Stock trades at $34.2 (market cap $3.04B). The key difference: HCA Health Inc is far larger — about 33.5× Liquidia Corporation Common Stock's market cap, and HCA Health Inc pays a 0.66% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Liquidia Corporation Common Stock for 0 Days on average.
| HCA | LQDA | |
|---|---|---|
Market Cap | $101.85B | $3.04B |
Volume | 1,081,388 | 21,111,778 |
Sector | Health | Health |
52-Week High | $545.13 | $91.03 |
52-Week Low | $361.32 | $22.02 |
Typical Hold Time | 76 Days | 0 Days |
Enterprise Value | $152.39B | $2.94B |
Dividend Yield | 0.66% | — |
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $460.75, up 0.47% today, with a bullish technical outlook and strong fundamental performance. The stock shows consistent earnings beats, with Q2 2026 EPS of $7.59 exceeding expectations. Revenue grew to $75.60 billion in 2025, and net income reached $6.78 billion. Analyst consensus is bullish, with a $461.12 price target. Recent news includes an upcoming Q3 2026 earnings call and ongoing legal investigations.
Outlook remains positive due to solid demand and cost controls, but risks include regulatory scrutiny and debt levels. The stock offers growth potential from operational efficiency, though investors should monitor legal developments and payer-mix pressures. Valuation metrics like a P/E of 15.45 suggest reasonable pricing relative to earnings.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →